David A. Fruman PhD

David Fruman is a Professor at UC Irvine where he has been a faculty member since 2000. In 2016 he was elected as an AAAS Fellow. His research interest is signal transduction in lymphocytes, with an emphasis on targeted therapies for blood cancer and immune diseases. He previously served as Associate Director of the UCI Institute for Immunology and is currently the Director of the UCI Cancer Research Institute. He is also Associate Director for Basic Science of the UCI Chao Family Comprehensive Cancer Center.

Professor Fruman has a strong interest in graduate education and was Director of the Cellular & Molecular Biosciences Ph.D. program from 2011-2015. From 2014-2019 he was Director of the GPS-BIOMED program, supported by an NIH-BEST grant, which enhanced the professional development of UCI graduate students and postdoctoral fellows in the biomedical sciences. He now serves as Academic Director of the program, under its new name GPS-STEM. In the fall of 2020, he began a new role at UCI, as Director of the Masters in Biotechnology Management (MSBTM) Program.